Vitamin D supplementation, lung function and asthma control in children with asthma and low vitamin D levels

Yueh Ying Han; Erick Forno; Leonard B. Bacharier; Wanda Phipatanakul; Theresa W. Guilbert; Michael D. Cabana; Kristie Ross; Joshua Blatter; Franziska J. Rosser; Sandy Durrani; James Luther; Stephen R. Wisniewski; Juan C. Celedón

doi:10.1183/13993003.00989-2021

Vitamin D supplementation, lung function and asthma control in children with asthma and low vitamin D levels

Yueh Ying Han, Erick Forno, Leonard B. Bacharier, Wanda Phipatanakul, Theresa W. Guilbert, Michael D. Cabana, Kristie Ross, Joshua Blatter, Franziska J. Rosser, Sandy Durrani, James Luther, Stephen R. Wisniewski, Juan C. Celedón

Research output: Contribution to journal › Letter › peer-review

Original language	English
Article number	A7
Journal	European Respiratory Journal
Volume	58
Issue number	4
DOIs	https://doi.org/10.1183/13993003.00989-2021
State	Published - Oct 1 2021

Access to Document

10.1183/13993003.00989-2021

Cite this

Han, Y. Y., Forno, E., Bacharier, L. B., Phipatanakul, W., Guilbert, T. W., Cabana, M. D., Ross, K., Blatter, J., Rosser, F. J., Durrani, S., Luther, J., Wisniewski, S. R., & Celedón, J. C. (2021). Vitamin D supplementation, lung function and asthma control in children with asthma and low vitamin D levels. European Respiratory Journal, 58(4), [A7]. https://doi.org/10.1183/13993003.00989-2021

@article{2122193c67fe47d0ad8db539a77ed9c1,

title = "Vitamin D supplementation, lung function and asthma control in children with asthma and low vitamin D levels",

author = "Han, {Yueh Ying} and Erick Forno and Bacharier, {Leonard B.} and Wanda Phipatanakul and Guilbert, {Theresa W.} and Cabana, {Michael D.} and Kristie Ross and Joshua Blatter and Rosser, {Franziska J.} and Sandy Durrani and James Luther and Wisniewski, {Stephen R.} and Celed{\'o}n, {Juan C.}",

note = "Funding Information: Conflict of interest: Y-Y. Han has nothing to disclose. E. Forno has nothing to disclose. L.B. Bacharier has nothing to disclose. W. Phipatanakul reports personal fees for consultancy from GSK, Genentech, Novartis, Regeneron, Sanofi and Teva, grants from Genentech, Novartis, Regeneron, Sanofi, Circassia, Monaghen, Thermo Fisher, Alk Abello, Lincoln Diagnostics, GSK, Kaleo and Merck, institutional grants from Genentech, Regeneron, Novartis and the US NIH, outside the submitted work. T.W. Guilbert reports personal fees for consultancy from American Board of Pediatrics (Pediatric Pulmonary Sub-board), GSK, TEVA and Sanofi/Regeneron, grants from AstraZeneca, Novartis and Sanofi/Regeneron, non-financial support from Up To Date, outside the submitted work. M.D. Cabana is a member of the United States Preventive Services Task Force (USPSTF), outside the submitted work. K. Ross has nothing to disclose. J. Blatter has nothing to disclose. F.J. Rosser has nothing to disclose. S. Durrani has nothing to disclose. J. Luther has nothing to disclose. S.R. Wisniewski has nothing to disclose. J.C. Celed{\'o}n reports non-financial support (study medication) from Pharmavite and GSK, during the conduct of the study; non-financial support (study medication) from Merck, outside the submitted work. Funding Information: Support statement: This study was funded by grant HL119952 from the US National Institutes of Health (NIH). The project was also supported by the Pediatric Clinical and Translational Research Center (PCTRC) at the University of Pittsburgh Medical Center Children{\textquoteright}s Hospital of Pittsburgh through NIH grant UL1TR001857. F.J. Rosser{\textquoteright}s contribution was supported by grant KL2 TR001856 from the NIH. Pharmavite LLC provided the vitamin D and placebo capsules for the study, and GlaxoSmithKline provided the Flovent given to study participants. Funding information for this article has been deposited with the Crossref Funder Registry.",

year = "2021",

month = oct,

day = "1",

doi = "10.1183/13993003.00989-2021",

language = "English",

volume = "58",

journal = "European Respiratory Journal",

issn = "0903-1936",

number = "4",

}

Han, YY, Forno, E, Bacharier, LB, Phipatanakul, W, Guilbert, TW, Cabana, MD, Ross, K, Blatter, J, Rosser, FJ, Durrani, S, Luther, J, Wisniewski, SR & Celedón, JC 2021, 'Vitamin D supplementation, lung function and asthma control in children with asthma and low vitamin D levels', European Respiratory Journal, vol. 58, no. 4, A7. https://doi.org/10.1183/13993003.00989-2021

TY - JOUR

T1 - Vitamin D supplementation, lung function and asthma control in children with asthma and low vitamin D levels

AU - Han, Yueh Ying

AU - Forno, Erick

AU - Bacharier, Leonard B.

AU - Phipatanakul, Wanda

AU - Guilbert, Theresa W.

AU - Cabana, Michael D.

AU - Ross, Kristie

AU - Blatter, Joshua

AU - Rosser, Franziska J.

AU - Durrani, Sandy

AU - Luther, James

AU - Wisniewski, Stephen R.

AU - Celedón, Juan C.

N1 - Funding Information: Conflict of interest: Y-Y. Han has nothing to disclose. E. Forno has nothing to disclose. L.B. Bacharier has nothing to disclose. W. Phipatanakul reports personal fees for consultancy from GSK, Genentech, Novartis, Regeneron, Sanofi and Teva, grants from Genentech, Novartis, Regeneron, Sanofi, Circassia, Monaghen, Thermo Fisher, Alk Abello, Lincoln Diagnostics, GSK, Kaleo and Merck, institutional grants from Genentech, Regeneron, Novartis and the US NIH, outside the submitted work. T.W. Guilbert reports personal fees for consultancy from American Board of Pediatrics (Pediatric Pulmonary Sub-board), GSK, TEVA and Sanofi/Regeneron, grants from AstraZeneca, Novartis and Sanofi/Regeneron, non-financial support from Up To Date, outside the submitted work. M.D. Cabana is a member of the United States Preventive Services Task Force (USPSTF), outside the submitted work. K. Ross has nothing to disclose. J. Blatter has nothing to disclose. F.J. Rosser has nothing to disclose. S. Durrani has nothing to disclose. J. Luther has nothing to disclose. S.R. Wisniewski has nothing to disclose. J.C. Celedón reports non-financial support (study medication) from Pharmavite and GSK, during the conduct of the study; non-financial support (study medication) from Merck, outside the submitted work. Funding Information: Support statement: This study was funded by grant HL119952 from the US National Institutes of Health (NIH). The project was also supported by the Pediatric Clinical and Translational Research Center (PCTRC) at the University of Pittsburgh Medical Center Children’s Hospital of Pittsburgh through NIH grant UL1TR001857. F.J. Rosser’s contribution was supported by grant KL2 TR001856 from the NIH. Pharmavite LLC provided the vitamin D and placebo capsules for the study, and GlaxoSmithKline provided the Flovent given to study participants. Funding information for this article has been deposited with the Crossref Funder Registry.

PY - 2021/10/1

Y1 - 2021/10/1

UR - http://www.scopus.com/inward/record.url?scp=85119457106&partnerID=8YFLogxK

U2 - 10.1183/13993003.00989-2021

DO - 10.1183/13993003.00989-2021

M3 - Letter

C2 - 34326185

AN - SCOPUS:85119457106

VL - 58

JO - European Respiratory Journal

JF - European Respiratory Journal

SN - 0903-1936

IS - 4

M1 - A7

ER -

Vitamin D supplementation, lung function and asthma control in children with asthma and low vitamin D levels

Access to Document

Other files and links

Cite this